Vanda Pharmaceuticals Inc.
VNDA
$5.25
-$0.08-1.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.51M | -48.57M | -141.19M | -22.59M | -27.21M |
| Total Depreciation and Amortization | 3.71M | 3.53M | 5.86M | 2.05M | 2.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.56M | 2.71M | 102.88M | -2.97M | -6.26M |
| Change in Net Operating Assets | 25.18M | -7.89M | 3.03M | -8.13M | 15.32M |
| Cash from Operations | -31.07M | -50.22M | -29.42M | -31.63M | -15.25M |
| Capital Expenditure | -190.00K | -221.00K | -102.00K | -161.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.00M | 20.46M | 44.97M | 21.52M | -14.97M |
| Cash from Investing | 33.81M | 20.23M | 44.87M | 21.36M | -15.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -856.00K | -776.00K | -640.00K | -517.00K | -425.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -856.00K | -776.00K | -640.00K | -517.00K | -425.00K |
| Foreign Exchange rate Adjustments | -36.00K | -57.00K | 20.00K | -180.00K | 134.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.85M | -30.82M | 14.83M | -10.96M | -30.81M |